FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016804660> ?p ?o ?g. }

• W2016804660 endingPage "576" @default.
• W2016804660 startingPage "573" @default.
• W2016804660 abstract "Objective: The presence of phosphatidylglycerol in amniotic fluid from the vaginal pool has been established as a reliable marker of pulmonary maturity in pregnancies complicated by preterm premature rupture of membranes because its presence is not affected by contaminants. This study was undertaken to determine the distribution of positive phosphatidylglycerol relative to gestational age from vaginal pool amniotic fluid samples and to assess the efficacy and accuracy of the Amniostat-FLM (Hana Biologies; Irvine Scientific after Sept. 14, 1989), an antibody agglutination method for rapidly detecting phosphatidylglycerol. Study design: All singleton nondiabetic pregnancies between 26 and 36 weeks with premature rupture of membranes from whom a vaginal pool sample was obtained were studied. The percent positive by gestational age was analyzed. The neonates that were delivered with a positive phosphatidylglycerol were evaluated for the presence of hyaline membrane disease and other immediate sequelae of prematurity. Results: Of the 201 vaginal pool amniotic fluid samples assayed for phosphatidylglycerol with the Amniostat-FLM procedure, 18% (36/201) were positive for phosphatidylglycerol and none of the delivered infants developed hyaline membrane disease. Conclusion: The Amniostat-FLM seems to be accurate in predicting pulmonary maturity from vaginal pool samples. Objective: The presence of phosphatidylglycerol in amniotic fluid from the vaginal pool has been established as a reliable marker of pulmonary maturity in pregnancies complicated by preterm premature rupture of membranes because its presence is not affected by contaminants. This study was undertaken to determine the distribution of positive phosphatidylglycerol relative to gestational age from vaginal pool amniotic fluid samples and to assess the efficacy and accuracy of the Amniostat-FLM (Hana Biologies; Irvine Scientific after Sept. 14, 1989), an antibody agglutination method for rapidly detecting phosphatidylglycerol. Study design: All singleton nondiabetic pregnancies between 26 and 36 weeks with premature rupture of membranes from whom a vaginal pool sample was obtained were studied. The percent positive by gestational age was analyzed. The neonates that were delivered with a positive phosphatidylglycerol were evaluated for the presence of hyaline membrane disease and other immediate sequelae of prematurity. Results: Of the 201 vaginal pool amniotic fluid samples assayed for phosphatidylglycerol with the Amniostat-FLM procedure, 18% (36/201) were positive for phosphatidylglycerol and none of the delivered infants developed hyaline membrane disease. Conclusion: The Amniostat-FLM seems to be accurate in predicting pulmonary maturity from vaginal pool samples." @default.
• W2016804660 created "2016-06-24" @default.
• W2016804660 creator A5013063444 @default.
• W2016804660 creator A5033226763 @default.
• W2016804660 creator A5033302847 @default.
• W2016804660 creator A5035329902 @default.
• W2016804660 creator A5039035652 @default.
• W2016804660 creator A5089054133 @default.
• W2016804660 creator A5089072694 @default.
• W2016804660 date "1993-09-01" @default.
• W2016804660 modified "2023-10-06" @default.
• W2016804660 title "Use of Amniostat-FLM in detecting the presence of phosphatidylglycerol in vaginal pool samples in preterm premature rupture of membranes" @default.
• W2016804660 cites W1548996036 @default.
• W2016804660 cites W1660510802 @default.
• W2016804660 cites W1808356678 @default.
• W2016804660 cites W1821307840 @default.
• W2016804660 cites W1862817131 @default.
• W2016804660 cites W2000937336 @default.
• W2016804660 cites W2021137354 @default.
• W2016804660 cites W2038142256 @default.
• W2016804660 cites W2046851122 @default.
• W2016804660 cites W2060664410 @default.
• W2016804660 cites W2090215238 @default.
• W2016804660 cites W2128770527 @default.
• W2016804660 cites W2209730938 @default.
• W2016804660 cites W2210580959 @default.
• W2016804660 cites W4301791589 @default.
• W2016804660 doi "https://doi.org/10.1016/0002-9378(93)90624-r" @default.
• W2016804660 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8372866" @default.
• W2016804660 hasPublicationYear "1993" @default.
• W2016804660 type Work @default.
• W2016804660 sameAs 2016804660 @default.
• W2016804660 citedByCount "12" @default.
• W2016804660 countsByYear W20168046602014 @default.
• W2016804660 countsByYear W20168046602017 @default.
• W2016804660 countsByYear W20168046602021 @default.
• W2016804660 crossrefType "journal-article" @default.
• W2016804660 hasAuthorship W2016804660A5013063444 @default.
• W2016804660 hasAuthorship W2016804660A5033226763 @default.
• W2016804660 hasAuthorship W2016804660A5033302847 @default.
• W2016804660 hasAuthorship W2016804660A5035329902 @default.
• W2016804660 hasAuthorship W2016804660A5039035652 @default.
• W2016804660 hasAuthorship W2016804660A5089054133 @default.
• W2016804660 hasAuthorship W2016804660A5089072694 @default.
• W2016804660 hasConcept C118494813 @default.
• W2016804660 hasConcept C131872663 @default.
• W2016804660 hasConcept C142724271 @default.
• W2016804660 hasConcept C172680121 @default.
• W2016804660 hasConcept C2776330855 @default.
• W2016804660 hasConcept C2777102558 @default.
• W2016804660 hasConcept C2778194526 @default.
• W2016804660 hasConcept C2778376644 @default.
• W2016804660 hasConcept C2778918659 @default.
• W2016804660 hasConcept C2779234561 @default.
• W2016804660 hasConcept C2780726299 @default.
• W2016804660 hasConcept C29456083 @default.
• W2016804660 hasConcept C41625074 @default.
• W2016804660 hasConcept C54355233 @default.
• W2016804660 hasConcept C71924100 @default.
• W2016804660 hasConcept C86803240 @default.
• W2016804660 hasConceptScore W2016804660C118494813 @default.
• W2016804660 hasConceptScore W2016804660C131872663 @default.
• W2016804660 hasConceptScore W2016804660C142724271 @default.
• W2016804660 hasConceptScore W2016804660C172680121 @default.
• W2016804660 hasConceptScore W2016804660C2776330855 @default.
• W2016804660 hasConceptScore W2016804660C2777102558 @default.
• W2016804660 hasConceptScore W2016804660C2778194526 @default.
• W2016804660 hasConceptScore W2016804660C2778376644 @default.
• W2016804660 hasConceptScore W2016804660C2778918659 @default.
• W2016804660 hasConceptScore W2016804660C2779234561 @default.
• W2016804660 hasConceptScore W2016804660C2780726299 @default.
• W2016804660 hasConceptScore W2016804660C29456083 @default.
• W2016804660 hasConceptScore W2016804660C41625074 @default.
• W2016804660 hasConceptScore W2016804660C54355233 @default.
• W2016804660 hasConceptScore W2016804660C71924100 @default.
• W2016804660 hasConceptScore W2016804660C86803240 @default.
• W2016804660 hasIssue "3" @default.
• W2016804660 hasLocation W20168046601 @default.
• W2016804660 hasLocation W20168046602 @default.
• W2016804660 hasOpenAccess W2016804660 @default.
• W2016804660 hasPrimaryLocation W20168046601 @default.
• W2016804660 hasRelatedWork W128197492 @default.
• W2016804660 hasRelatedWork W1660510802 @default.
• W2016804660 hasRelatedWork W2016804660 @default.
• W2016804660 hasRelatedWork W2033441060 @default.
• W2016804660 hasRelatedWork W2054565408 @default.
• W2016804660 hasRelatedWork W2055941334 @default.
• W2016804660 hasRelatedWork W2333891256 @default.
• W2016804660 hasRelatedWork W2417098985 @default.
• W2016804660 hasRelatedWork W2468370108 @default.
• W2016804660 hasRelatedWork W3021211312 @default.
• W2016804660 hasVolume "169" @default.
• W2016804660 isParatext "false" @default.
• W2016804660 isRetracted "false" @default.
• W2016804660 magId "2016804660" @default.
• W2016804660 workType "article" @default.